SeaStar Medical Holding Corp (ICUCW) stock
ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)
Close on Oct 30, 2026Market cap $9.87MP/E –Yield –
SeaStar Medical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
SeaStar Medical's EPS for the twelve months ending Jun 30, 2026 was -$3.93. For fiscal 2024 it was -$66.30.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$66.30 | – |
| FY2023 | Dec 31, 2023 | -$302.60 | – |
| FY2022 | Dec 31, 2022 | -$370.00 | – |
| FY2021 | Dec 31, 2021 | -$157.50 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.91 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.90 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.80 | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.32 | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.80 | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.40 | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.97 | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.00 | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.30 | – |
| Q1 FY2024 | Mar 31, 2024 | -$47.30 | – |
| Q4 FY2023 | Dec 31, 2023 | -$61.26 | – |
| Q3 FY2023 | Sep 30, 2023 | -$90.20 | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.00 | – |
| Q1 FY2023 | Mar 31, 2023 | -$135.00 | – |
| Q4 FY2022 | Dec 31, 2022 | -$188.52 | – |
| Q3 FY2022 | Sep 30, 2022 | -$65.00 | -244.4% |
| Q2 FY2022 | Jun 30, 2022 | -$30.00 | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.00 | – |
| Q2 FY2021 | Jun 30, 2021 | -$37.50 | – |
| Q1 FY2021 | Mar 31, 2021 | $45.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics